nodes	percent_of_prediction	percent_of_DWPC	metapath
Sunitinib—ERN1—epilepsy syndrome	0.143	0.325	CbGaD
Sunitinib—TYRO3—epilepsy syndrome	0.0819	0.186	CbGaD
Sunitinib—FYN—epilepsy syndrome	0.0621	0.141	CbGaD
Sunitinib—PTK2B—epilepsy syndrome	0.0528	0.12	CbGaD
Sunitinib—RET—epilepsy syndrome	0.0449	0.102	CbGaD
Sunitinib—KDR—epilepsy syndrome	0.0236	0.0537	CbGaD
Sunitinib—ABCC2—Levetiracetam—epilepsy syndrome	0.0181	0.0889	CbGbCtD
Sunitinib—ABCC2—epilepsy syndrome	0.0139	0.0317	CbGaD
Sunitinib—ABCG2—epilepsy syndrome	0.0123	0.028	CbGaD
Sunitinib—ABCC2—Carbamazepine—epilepsy syndrome	0.0104	0.0511	CbGbCtD
Sunitinib—ABCC2—Phenytoin—epilepsy syndrome	0.00933	0.0458	CbGbCtD
Sunitinib—ABCC2—Phenobarbital—epilepsy syndrome	0.00831	0.0408	CbGbCtD
Sunitinib—CYP3A5—Oxcarbazepine—epilepsy syndrome	0.00829	0.0407	CbGbCtD
Sunitinib—CYP3A7-CYP3A51P—Carbamazepine—epilepsy syndrome	0.00694	0.0341	CbGbCtD
Sunitinib—CYP3A7—Carbamazepine—epilepsy syndrome	0.00694	0.0341	CbGbCtD
Sunitinib—CYP3A7—Phenytoin—epilepsy syndrome	0.00623	0.0306	CbGbCtD
Sunitinib—CYP3A7-CYP3A51P—Phenytoin—epilepsy syndrome	0.00623	0.0306	CbGbCtD
Sunitinib—ABCB1—Levetiracetam—epilepsy syndrome	0.0059	0.029	CbGbCtD
Sunitinib—CYP3A7-CYP3A51P—Phenobarbital—epilepsy syndrome	0.00555	0.0273	CbGbCtD
Sunitinib—CYP3A7—Phenobarbital—epilepsy syndrome	0.00555	0.0273	CbGbCtD
Sunitinib—CYP3A7—Midazolam—epilepsy syndrome	0.00547	0.0269	CbGbCtD
Sunitinib—CYP3A7-CYP3A51P—Midazolam—epilepsy syndrome	0.00547	0.0269	CbGbCtD
Sunitinib—CYP3A7—Diazepam—epilepsy syndrome	0.00526	0.0258	CbGbCtD
Sunitinib—CYP3A7-CYP3A51P—Diazepam—epilepsy syndrome	0.00526	0.0258	CbGbCtD
Sunitinib—CYP3A5—Carbamazepine—epilepsy syndrome	0.00521	0.0256	CbGbCtD
Sunitinib—ABCB1—epilepsy syndrome	0.00513	0.0117	CbGaD
Sunitinib—CYP3A5—Phenytoin—epilepsy syndrome	0.00467	0.0229	CbGbCtD
Sunitinib—CYP3A5—Phenobarbital—epilepsy syndrome	0.00416	0.0204	CbGbCtD
Sunitinib—CYP3A5—Midazolam—epilepsy syndrome	0.00411	0.0202	CbGbCtD
Sunitinib—ABCB1—Clobazam—epilepsy syndrome	0.00409	0.0201	CbGbCtD
Sunitinib—CYP3A5—Diazepam—epilepsy syndrome	0.00395	0.0194	CbGbCtD
Sunitinib—ABCB1—Lamotrigine—epilepsy syndrome	0.00394	0.0193	CbGbCtD
Sunitinib—ABCB1—Carbamazepine—epilepsy syndrome	0.00339	0.0166	CbGbCtD
Sunitinib—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.00323	0.0159	CbGbCtD
Sunitinib—CYP3A5—Valproic Acid—epilepsy syndrome	0.00311	0.0153	CbGbCtD
Sunitinib—ABCB1—Phenytoin—epilepsy syndrome	0.00304	0.0149	CbGbCtD
Sunitinib—CYP3A4—Trimethadione—epilepsy syndrome	0.00301	0.0148	CbGbCtD
Sunitinib—CYP3A4—Felbamate—epilepsy syndrome	0.00301	0.0148	CbGbCtD
Sunitinib—CYP3A4—Fosphenytoin—epilepsy syndrome	0.00283	0.0139	CbGbCtD
Sunitinib—ABCB1—Phenobarbital—epilepsy syndrome	0.00271	0.0133	CbGbCtD
Sunitinib—ABCB1—Midazolam—epilepsy syndrome	0.00267	0.0131	CbGbCtD
Sunitinib—ABCB1—Diazepam—epilepsy syndrome	0.00257	0.0126	CbGbCtD
Sunitinib—CYP3A4—Clonazepam—epilepsy syndrome	0.00256	0.0126	CbGbCtD
Sunitinib—CYP3A4—Clobazam—epilepsy syndrome	0.00245	0.012	CbGbCtD
Sunitinib—CYP3A4—Rufinamide—epilepsy syndrome	0.00208	0.0102	CbGbCtD
Sunitinib—CYP3A4—Carbamazepine—epilepsy syndrome	0.00203	0.00997	CbGbCtD
Sunitinib—CYP3A4—Primidone—epilepsy syndrome	0.0019	0.00931	CbGbCtD
Sunitinib—CYP3A4—Phenytoin—epilepsy syndrome	0.00182	0.00894	CbGbCtD
Sunitinib—CYP3A4—Propofol—epilepsy syndrome	0.0017	0.00834	CbGbCtD
Sunitinib—CYP3A4—Acetazolamide—epilepsy syndrome	0.00162	0.00797	CbGbCtD
Sunitinib—CYP3A4—Phenobarbital—epilepsy syndrome	0.00162	0.00797	CbGbCtD
Sunitinib—CYP3A4—Midazolam—epilepsy syndrome	0.0016	0.00786	CbGbCtD
Sunitinib—CYP3A4—Diazepam—epilepsy syndrome	0.00154	0.00756	CbGbCtD
Sunitinib—CYP3A4—Zonisamide—epilepsy syndrome	0.0015	0.00738	CbGbCtD
Sunitinib—RPS6KA1—Pyrimethamine—Lamotrigine—epilepsy syndrome	0.00132	0.681	CbGdCrCtD
Sunitinib—CYP3A4—Valproic Acid—epilepsy syndrome	0.00121	0.00596	CbGbCtD
Sunitinib—CYP3A4—Topiramate—epilepsy syndrome	0.00109	0.00538	CbGbCtD
Sunitinib—Procainamide—SCN8A—epilepsy syndrome	0.000535	0.175	CrCbGaD
Sunitinib—Procainamide—SCN9A—epilepsy syndrome	0.000433	0.142	CrCbGaD
Sunitinib—Procainamide—SCN3A—epilepsy syndrome	0.000414	0.135	CrCbGaD
Sunitinib—Procainamide—SCN4A—epilepsy syndrome	0.000397	0.13	CrCbGaD
Sunitinib—Procainamide—SCN1A—epilepsy syndrome	0.00029	0.0951	CrCbGaD
Sunitinib—Metoclopramide—CHRM1—epilepsy syndrome	0.000285	0.0933	CrCbGaD
Sunitinib—PIP4K2B—Bortezomib—Lacosamide—epilepsy syndrome	0.000258	0.133	CbGdCrCtD
Sunitinib—Procainamide—SCN2A—epilepsy syndrome	0.000256	0.0838	CrCbGaD
Sunitinib—Procainamide—CHRM2—epilepsy syndrome	0.000148	0.0484	CrCbGaD
Sunitinib—Procainamide—BCHE—epilepsy syndrome	0.000123	0.0403	CrCbGaD
Sunitinib—Metoclopramide—CYP2D6—epilepsy syndrome	0.000106	0.0349	CrCbGaD
Sunitinib—PRPF4—Promazine—Carbamazepine—epilepsy syndrome	0.000105	0.0542	CbGdCrCtD
Sunitinib—PRPF4—Promazine—Oxcarbazepine—epilepsy syndrome	9.69e-05	0.0499	CbGdCrCtD
Sunitinib—PRPF4—Niclosamide—Clonazepam—epilepsy syndrome	8.47e-05	0.0437	CbGdCrCtD
Sunitinib—PRPF4—Chlorpromazine—Clobazam—epilepsy syndrome	7.26e-05	0.0374	CbGdCrCtD
Sunitinib—Procainamide—CYP2D6—epilepsy syndrome	6.76e-05	0.0221	CrCbGaD
Sunitinib—CSNK1A1—cerebellum—epilepsy syndrome	6.62e-05	0.000785	CbGeAlD
Sunitinib—MAP2K2—head—epilepsy syndrome	6.62e-05	0.000785	CbGeAlD
Sunitinib—ULK3—head—epilepsy syndrome	6.62e-05	0.000785	CbGeAlD
Sunitinib—FYN—midbrain—epilepsy syndrome	6.61e-05	0.000785	CbGeAlD
Sunitinib—CAMK2G—central nervous system—epilepsy syndrome	6.6e-05	0.000784	CbGeAlD
Sunitinib—BMP2K—central nervous system—epilepsy syndrome	6.6e-05	0.000784	CbGeAlD
Sunitinib—FGFR2—spinal cord—epilepsy syndrome	6.58e-05	0.00078	CbGeAlD
Sunitinib—CLK1—cerebellum—epilepsy syndrome	6.58e-05	0.00078	CbGeAlD
Sunitinib—STK16—brain—epilepsy syndrome	6.57e-05	0.00078	CbGeAlD
Sunitinib—MAP3K2—head—epilepsy syndrome	6.57e-05	0.00078	CbGeAlD
Sunitinib—LRRK2—central nervous system—epilepsy syndrome	6.54e-05	0.000777	CbGeAlD
Sunitinib—JAK2—spinal cord—epilepsy syndrome	6.54e-05	0.000776	CbGeAlD
Sunitinib—HIPK3—brain—epilepsy syndrome	6.54e-05	0.000776	CbGeAlD
Sunitinib—ALK—brain—epilepsy syndrome	6.54e-05	0.000776	CbGeAlD
Sunitinib—TYRO3—brain—epilepsy syndrome	6.54e-05	0.000776	CbGeAlD
Sunitinib—HIPK2—brain—epilepsy syndrome	6.54e-05	0.000776	CbGeAlD
Sunitinib—YES1—medulla oblongata—epilepsy syndrome	6.53e-05	0.000775	CbGeAlD
Sunitinib—KIT—telencephalon—epilepsy syndrome	6.52e-05	0.000773	CbGeAlD
Sunitinib—CSNK1E—nervous system—epilepsy syndrome	6.52e-05	0.000773	CbGeAlD
Sunitinib—TNK1—brain—epilepsy syndrome	6.47e-05	0.000768	CbGeAlD
Sunitinib—RIOK2—brain—epilepsy syndrome	6.47e-05	0.000768	CbGeAlD
Sunitinib—MAP3K3—midbrain—epilepsy syndrome	6.46e-05	0.000767	CbGeAlD
Sunitinib—MAP4K5—midbrain—epilepsy syndrome	6.46e-05	0.000767	CbGeAlD
Sunitinib—CAMK2G—cerebellum—epilepsy syndrome	6.45e-05	0.000766	CbGeAlD
Sunitinib—BMP2K—cerebellum—epilepsy syndrome	6.45e-05	0.000766	CbGeAlD
Sunitinib—FYN—spinal cord—epilepsy syndrome	6.45e-05	0.000766	CbGeAlD
Sunitinib—PRKAA1—central nervous system—epilepsy syndrome	6.45e-05	0.000765	CbGeAlD
Sunitinib—TAOK3—medulla oblongata—epilepsy syndrome	6.45e-05	0.000765	CbGeAlD
Sunitinib—TBK1—head—epilepsy syndrome	6.43e-05	0.000763	CbGeAlD
Sunitinib—IRAK4—nervous system—epilepsy syndrome	6.42e-05	0.000761	CbGeAlD
Sunitinib—MAP4K1—brain—epilepsy syndrome	6.41e-05	0.00076	CbGeAlD
Sunitinib—MAP3K19—brain—epilepsy syndrome	6.41e-05	0.00076	CbGeAlD
Sunitinib—LRRK2—cerebellum—epilepsy syndrome	6.4e-05	0.000759	CbGeAlD
Sunitinib—TYK2—head—epilepsy syndrome	6.39e-05	0.000758	CbGeAlD
Sunitinib—PTK2B—central nervous system—epilepsy syndrome	6.38e-05	0.000757	CbGeAlD
Sunitinib—PDGFRB—telencephalon—epilepsy syndrome	6.37e-05	0.000755	CbGeAlD
Sunitinib—MAP3K3—spinal cord—epilepsy syndrome	6.3e-05	0.000748	CbGeAlD
Sunitinib—MAP4K5—spinal cord—epilepsy syndrome	6.3e-05	0.000748	CbGeAlD
Sunitinib—PRKAA1—cerebellum—epilepsy syndrome	6.3e-05	0.000748	CbGeAlD
Sunitinib—DAPK3—brain—epilepsy syndrome	6.28e-05	0.000745	CbGeAlD
Sunitinib—CSNK1E—central nervous system—epilepsy syndrome	6.27e-05	0.000745	CbGeAlD
Sunitinib—MAP2K2—nervous system—epilepsy syndrome	6.27e-05	0.000744	CbGeAlD
Sunitinib—ULK3—nervous system—epilepsy syndrome	6.27e-05	0.000744	CbGeAlD
Sunitinib—FLT1—midbrain—epilepsy syndrome	6.25e-05	0.000741	CbGeAlD
Sunitinib—PTK2B—cerebellum—epilepsy syndrome	6.23e-05	0.00074	CbGeAlD
Sunitinib—MAP3K2—nervous system—epilepsy syndrome	6.23e-05	0.000739	CbGeAlD
Sunitinib—CLK2—brain—epilepsy syndrome	6.22e-05	0.000738	CbGeAlD
Sunitinib—MAP4K2—brain—epilepsy syndrome	6.19e-05	0.000735	CbGeAlD
Sunitinib—RPS6KB1—head—epilepsy syndrome	6.19e-05	0.000734	CbGeAlD
Sunitinib—IRAK4—central nervous system—epilepsy syndrome	6.18e-05	0.000733	CbGeAlD
Sunitinib—EPHB6—midbrain—epilepsy syndrome	6.18e-05	0.000733	CbGeAlD
Sunitinib—FGR—head—epilepsy syndrome	6.15e-05	0.00073	CbGeAlD
Sunitinib—RET—head—epilepsy syndrome	6.15e-05	0.00073	CbGeAlD
Sunitinib—CSNK1E—cerebellum—epilepsy syndrome	6.13e-05	0.000728	CbGeAlD
Sunitinib—FGFR1—cerebellum—epilepsy syndrome	6.13e-05	0.000728	CbGeAlD
Sunitinib—AXL—head—epilepsy syndrome	6.13e-05	0.000727	CbGeAlD
Sunitinib—STK3—brain—epilepsy syndrome	6.11e-05	0.000725	CbGeAlD
Sunitinib—TBK1—nervous system—epilepsy syndrome	6.1e-05	0.000724	CbGeAlD
Sunitinib—FLT1—spinal cord—epilepsy syndrome	6.1e-05	0.000723	CbGeAlD
Sunitinib—TYK2—nervous system—epilepsy syndrome	6.06e-05	0.000719	CbGeAlD
Sunitinib—ULK3—central nervous system—epilepsy syndrome	6.04e-05	0.000717	CbGeAlD
Sunitinib—MAP2K2—central nervous system—epilepsy syndrome	6.04e-05	0.000717	CbGeAlD
Sunitinib—IRAK4—cerebellum—epilepsy syndrome	6.04e-05	0.000716	CbGeAlD
Sunitinib—ROCK1—brain—epilepsy syndrome	6.03e-05	0.000716	CbGeAlD
Sunitinib—EPHB6—spinal cord—epilepsy syndrome	6.03e-05	0.000715	CbGeAlD
Sunitinib—MAP3K2—central nervous system—epilepsy syndrome	6e-05	0.000712	CbGeAlD
Sunitinib—YES1—midbrain—epilepsy syndrome	5.97e-05	0.000708	CbGeAlD
Sunitinib—ULK3—cerebellum—epilepsy syndrome	5.9e-05	0.000701	CbGeAlD
Sunitinib—MAP2K2—cerebellum—epilepsy syndrome	5.9e-05	0.000701	CbGeAlD
Sunitinib—TAOK3—midbrain—epilepsy syndrome	5.89e-05	0.000699	CbGeAlD
Sunitinib—DYRK1A—brain—epilepsy syndrome	5.88e-05	0.000698	CbGeAlD
Sunitinib—TBK1—central nervous system—epilepsy syndrome	5.87e-05	0.000697	CbGeAlD
Sunitinib—RPS6KB1—nervous system—epilepsy syndrome	5.87e-05	0.000696	CbGeAlD
Sunitinib—MAP3K2—cerebellum—epilepsy syndrome	5.86e-05	0.000695	CbGeAlD
Sunitinib—FGFR2—head—epilepsy syndrome	5.84e-05	0.000694	CbGeAlD
Sunitinib—TYK2—central nervous system—epilepsy syndrome	5.83e-05	0.000692	CbGeAlD
Sunitinib—RET—nervous system—epilepsy syndrome	5.83e-05	0.000692	CbGeAlD
Sunitinib—FGR—nervous system—epilepsy syndrome	5.83e-05	0.000692	CbGeAlD
Sunitinib—YES1—spinal cord—epilepsy syndrome	5.82e-05	0.000691	CbGeAlD
Sunitinib—JAK2—head—epilepsy syndrome	5.81e-05	0.00069	CbGeAlD
Sunitinib—AXL—nervous system—epilepsy syndrome	5.81e-05	0.000689	CbGeAlD
Sunitinib—MAP3K7—cerebellum—epilepsy syndrome	5.81e-05	0.000689	CbGeAlD
Sunitinib—KDR—medulla oblongata—epilepsy syndrome	5.78e-05	0.000686	CbGeAlD
Sunitinib—MAP2K5—medulla oblongata—epilepsy syndrome	5.78e-05	0.000686	CbGeAlD
Sunitinib—TAOK3—spinal cord—epilepsy syndrome	5.75e-05	0.000682	CbGeAlD
Sunitinib—MERTK—brain—epilepsy syndrome	5.74e-05	0.000682	CbGeAlD
Sunitinib—TBK1—cerebellum—epilepsy syndrome	5.74e-05	0.000681	CbGeAlD
Sunitinib—FYN—head—epilepsy syndrome	5.73e-05	0.00068	CbGeAlD
Sunitinib—PDGFRA—spinal cord—epilepsy syndrome	5.71e-05	0.000678	CbGeAlD
Sunitinib—TYK2—cerebellum—epilepsy syndrome	5.7e-05	0.000677	CbGeAlD
Sunitinib—RPS6KB1—central nervous system—epilepsy syndrome	5.65e-05	0.00067	CbGeAlD
Sunitinib—CSF1R—medulla oblongata—epilepsy syndrome	5.64e-05	0.000669	CbGeAlD
Sunitinib—MAP4K4—brain—epilepsy syndrome	5.64e-05	0.000669	CbGeAlD
Sunitinib—IRAK1—cerebellum—epilepsy syndrome	5.63e-05	0.000668	CbGeAlD
Sunitinib—RET—central nervous system—epilepsy syndrome	5.61e-05	0.000666	CbGeAlD
Sunitinib—FGR—central nervous system—epilepsy syndrome	5.61e-05	0.000666	CbGeAlD
Sunitinib—MAP4K5—head—epilepsy syndrome	5.6e-05	0.000665	CbGeAlD
Sunitinib—MAP3K3—head—epilepsy syndrome	5.6e-05	0.000665	CbGeAlD
Sunitinib—NUAK2—brain—epilepsy syndrome	5.6e-05	0.000664	CbGeAlD
Sunitinib—AXL—central nervous system—epilepsy syndrome	5.59e-05	0.000664	CbGeAlD
Sunitinib—MAP3K12—brain—epilepsy syndrome	5.56e-05	0.00066	CbGeAlD
Sunitinib—FGFR2—nervous system—epilepsy syndrome	5.54e-05	0.000658	CbGeAlD
Sunitinib—RPS6KB1—cerebellum—epilepsy syndrome	5.52e-05	0.000655	CbGeAlD
Sunitinib—ABCC4—forebrain—epilepsy syndrome	5.51e-05	0.000654	CbGeAlD
Sunitinib—JAK2—nervous system—epilepsy syndrome	5.51e-05	0.000654	CbGeAlD
Sunitinib—RET—cerebellum—epilepsy syndrome	5.49e-05	0.000651	CbGeAlD
Sunitinib—RPS6KA3—brain—epilepsy syndrome	5.48e-05	0.000651	CbGeAlD
Sunitinib—AXL—cerebellum—epilepsy syndrome	5.47e-05	0.000649	CbGeAlD
Sunitinib—MAP2K1—brain—epilepsy syndrome	5.45e-05	0.000646	CbGeAlD
Sunitinib—FYN—nervous system—epilepsy syndrome	5.44e-05	0.000645	CbGeAlD
Sunitinib—FLT1—head—epilepsy syndrome	5.42e-05	0.000643	CbGeAlD
Sunitinib—CSNK1A1—brain—epilepsy syndrome	5.38e-05	0.000638	CbGeAlD
Sunitinib—EPHB6—head—epilepsy syndrome	5.35e-05	0.000635	CbGeAlD
Sunitinib—CLK1—brain—epilepsy syndrome	5.34e-05	0.000634	CbGeAlD
Sunitinib—FGFR2—central nervous system—epilepsy syndrome	5.33e-05	0.000633	CbGeAlD
Sunitinib—MAP4K5—nervous system—epilepsy syndrome	5.31e-05	0.00063	CbGeAlD
Sunitinib—MAP3K3—nervous system—epilepsy syndrome	5.31e-05	0.00063	CbGeAlD
Sunitinib—JAK2—central nervous system—epilepsy syndrome	5.31e-05	0.00063	CbGeAlD
Sunitinib—KDR—midbrain—epilepsy syndrome	5.28e-05	0.000627	CbGeAlD
Sunitinib—MAP2K5—midbrain—epilepsy syndrome	5.28e-05	0.000627	CbGeAlD
Sunitinib—SLK—cerebellum—epilepsy syndrome	5.26e-05	0.000624	CbGeAlD
Sunitinib—BMP2K—brain—epilepsy syndrome	5.24e-05	0.000622	CbGeAlD
Sunitinib—CAMK2G—brain—epilepsy syndrome	5.24e-05	0.000622	CbGeAlD
Sunitinib—FYN—central nervous system—epilepsy syndrome	5.23e-05	0.000621	CbGeAlD
Sunitinib—FGFR2—cerebellum—epilepsy syndrome	5.21e-05	0.000619	CbGeAlD
Sunitinib—LRRK2—brain—epilepsy syndrome	5.2e-05	0.000617	CbGeAlD
Sunitinib—JAK2—cerebellum—epilepsy syndrome	5.19e-05	0.000616	CbGeAlD
Sunitinib—YES1—head—epilepsy syndrome	5.17e-05	0.000614	CbGeAlD
Sunitinib—CSF1R—midbrain—epilepsy syndrome	5.15e-05	0.000612	CbGeAlD
Sunitinib—KDR—spinal cord—epilepsy syndrome	5.15e-05	0.000611	CbGeAlD
Sunitinib—MAP2K5—spinal cord—epilepsy syndrome	5.15e-05	0.000611	CbGeAlD
Sunitinib—FLT1—nervous system—epilepsy syndrome	5.14e-05	0.00061	CbGeAlD
Sunitinib—STK10—head—epilepsy syndrome	5.13e-05	0.000609	CbGeAlD
Sunitinib—KIT—medulla oblongata—epilepsy syndrome	5.12e-05	0.000608	CbGeAlD
Sunitinib—PRKAA1—brain—epilepsy syndrome	5.12e-05	0.000608	CbGeAlD
Sunitinib—FYN—cerebellum—epilepsy syndrome	5.12e-05	0.000607	CbGeAlD
Sunitinib—MAP3K3—central nervous system—epilepsy syndrome	5.11e-05	0.000607	CbGeAlD
Sunitinib—MAP4K5—central nervous system—epilepsy syndrome	5.11e-05	0.000607	CbGeAlD
Sunitinib—TAOK3—head—epilepsy syndrome	5.11e-05	0.000606	CbGeAlD
Sunitinib—EPHB6—nervous system—epilepsy syndrome	5.08e-05	0.000602	CbGeAlD
Sunitinib—PDGFRA—head—epilepsy syndrome	5.08e-05	0.000602	CbGeAlD
Sunitinib—PTK2B—brain—epilepsy syndrome	5.06e-05	0.000601	CbGeAlD
Sunitinib—FLT4—brain—epilepsy syndrome	5.05e-05	0.000599	CbGeAlD
Sunitinib—CSF1R—spinal cord—epilepsy syndrome	5.03e-05	0.000597	CbGeAlD
Sunitinib—PDGFRB—medulla oblongata—epilepsy syndrome	5e-05	0.000594	CbGeAlD
Sunitinib—MAP4K5—cerebellum—epilepsy syndrome	5e-05	0.000593	CbGeAlD
Sunitinib—MAP3K3—cerebellum—epilepsy syndrome	5e-05	0.000593	CbGeAlD
Sunitinib—FGFR1—brain—epilepsy syndrome	4.98e-05	0.000591	CbGeAlD
Sunitinib—CSNK1E—brain—epilepsy syndrome	4.98e-05	0.000591	CbGeAlD
Sunitinib—FLT1—central nervous system—epilepsy syndrome	4.94e-05	0.000587	CbGeAlD
Sunitinib—YES1—nervous system—epilepsy syndrome	4.91e-05	0.000582	CbGeAlD
Sunitinib—IRAK4—brain—epilepsy syndrome	4.9e-05	0.000582	CbGeAlD
Sunitinib—EPHB6—central nervous system—epilepsy syndrome	4.89e-05	0.00058	CbGeAlD
Sunitinib—STK10—nervous system—epilepsy syndrome	4.86e-05	0.000577	CbGeAlD
Sunitinib—TAOK3—nervous system—epilepsy syndrome	4.84e-05	0.000575	CbGeAlD
Sunitinib—FLT1—cerebellum—epilepsy syndrome	4.83e-05	0.000574	CbGeAlD
Sunitinib—PDGFRA—nervous system—epilepsy syndrome	4.81e-05	0.000571	CbGeAlD
Sunitinib—ULK3—brain—epilepsy syndrome	4.79e-05	0.000569	CbGeAlD
Sunitinib—MAP2K2—brain—epilepsy syndrome	4.79e-05	0.000569	CbGeAlD
Sunitinib—EPHB6—cerebellum—epilepsy syndrome	4.78e-05	0.000567	CbGeAlD
Sunitinib—MAP3K2—brain—epilepsy syndrome	4.76e-05	0.000565	CbGeAlD
Sunitinib—YES1—central nervous system—epilepsy syndrome	4.72e-05	0.000561	CbGeAlD
Sunitinib—MAP3K7—brain—epilepsy syndrome	4.72e-05	0.00056	CbGeAlD
Sunitinib—STK10—central nervous system—epilepsy syndrome	4.68e-05	0.000555	CbGeAlD
Sunitinib—KIT—midbrain—epilepsy syndrome	4.68e-05	0.000555	CbGeAlD
Sunitinib—TAOK3—central nervous system—epilepsy syndrome	4.66e-05	0.000553	CbGeAlD
Sunitinib—TBK1—brain—epilepsy syndrome	4.66e-05	0.000553	CbGeAlD
Sunitinib—PDGFRA—central nervous system—epilepsy syndrome	4.63e-05	0.00055	CbGeAlD
Sunitinib—TYK2—brain—epilepsy syndrome	4.63e-05	0.00055	CbGeAlD
Sunitinib—YES1—cerebellum—epilepsy syndrome	4.62e-05	0.000548	CbGeAlD
Sunitinib—KDR—head—epilepsy syndrome	4.58e-05	0.000543	CbGeAlD
Sunitinib—MAP2K5—head—epilepsy syndrome	4.58e-05	0.000543	CbGeAlD
Sunitinib—STK10—cerebellum—epilepsy syndrome	4.58e-05	0.000543	CbGeAlD
Sunitinib—PDGFRB—midbrain—epilepsy syndrome	4.57e-05	0.000542	CbGeAlD
Sunitinib—IRAK1—brain—epilepsy syndrome	4.57e-05	0.000542	CbGeAlD
Sunitinib—KIT—spinal cord—epilepsy syndrome	4.57e-05	0.000542	CbGeAlD
Sunitinib—TAOK3—cerebellum—epilepsy syndrome	4.56e-05	0.000541	CbGeAlD
Sunitinib—PDGFRA—cerebellum—epilepsy syndrome	4.53e-05	0.000537	CbGeAlD
Sunitinib—RPS6KB1—brain—epilepsy syndrome	4.48e-05	0.000532	CbGeAlD
Sunitinib—CSF1R—head—epilepsy syndrome	4.47e-05	0.00053	CbGeAlD
Sunitinib—PDGFRB—spinal cord—epilepsy syndrome	4.46e-05	0.000529	CbGeAlD
Sunitinib—RET—brain—epilepsy syndrome	4.46e-05	0.000529	CbGeAlD
Sunitinib—FGR—brain—epilepsy syndrome	4.46e-05	0.000529	CbGeAlD
Sunitinib—AXL—brain—epilepsy syndrome	4.44e-05	0.000527	CbGeAlD
Sunitinib—KCNH2—forebrain—epilepsy syndrome	4.37e-05	0.000519	CbGeAlD
Sunitinib—KDR—nervous system—epilepsy syndrome	4.34e-05	0.000515	CbGeAlD
Sunitinib—MAP2K5—nervous system—epilepsy syndrome	4.34e-05	0.000515	CbGeAlD
Sunitinib—SLK—brain—epilepsy syndrome	4.27e-05	0.000507	CbGeAlD
Sunitinib—CSF1R—nervous system—epilepsy syndrome	4.24e-05	0.000503	CbGeAlD
Sunitinib—FGFR2—brain—epilepsy syndrome	4.24e-05	0.000503	CbGeAlD
Sunitinib—JAK2—brain—epilepsy syndrome	4.21e-05	0.0005	CbGeAlD
Sunitinib—KDR—central nervous system—epilepsy syndrome	4.18e-05	0.000496	CbGeAlD
Sunitinib—MAP2K5—central nervous system—epilepsy syndrome	4.18e-05	0.000496	CbGeAlD
Sunitinib—FYN—brain—epilepsy syndrome	4.16e-05	0.000493	CbGeAlD
Sunitinib—KDR—cerebellum—epilepsy syndrome	4.09e-05	0.000485	CbGeAlD
Sunitinib—MAP2K5—cerebellum—epilepsy syndrome	4.09e-05	0.000485	CbGeAlD
Sunitinib—CSF1R—central nervous system—epilepsy syndrome	4.08e-05	0.000484	CbGeAlD
Sunitinib—MAP4K5—brain—epilepsy syndrome	4.06e-05	0.000482	CbGeAlD
Sunitinib—MAP3K3—brain—epilepsy syndrome	4.06e-05	0.000482	CbGeAlD
Sunitinib—KIT—head—epilepsy syndrome	4.06e-05	0.000482	CbGeAlD
Sunitinib—KCNH2—telencephalon—epilepsy syndrome	4.02e-05	0.000477	CbGeAlD
Sunitinib—CSF1R—cerebellum—epilepsy syndrome	3.99e-05	0.000473	CbGeAlD
Sunitinib—PDGFRB—head—epilepsy syndrome	3.96e-05	0.00047	CbGeAlD
Sunitinib—FLT1—brain—epilepsy syndrome	3.93e-05	0.000466	CbGeAlD
Sunitinib—EPHB6—brain—epilepsy syndrome	3.88e-05	0.000461	CbGeAlD
Sunitinib—KIT—nervous system—epilepsy syndrome	3.85e-05	0.000457	CbGeAlD
Sunitinib—PDGFRB—nervous system—epilepsy syndrome	3.76e-05	0.000446	CbGeAlD
Sunitinib—YES1—brain—epilepsy syndrome	3.75e-05	0.000445	CbGeAlD
Sunitinib—STK10—brain—epilepsy syndrome	3.72e-05	0.000441	CbGeAlD
Sunitinib—KIT—central nervous system—epilepsy syndrome	3.7e-05	0.00044	CbGeAlD
Sunitinib—TAOK3—brain—epilepsy syndrome	3.7e-05	0.000439	CbGeAlD
Sunitinib—PDGFRA—brain—epilepsy syndrome	3.68e-05	0.000437	CbGeAlD
Sunitinib—KIT—cerebellum—epilepsy syndrome	3.62e-05	0.00043	CbGeAlD
Sunitinib—PDGFRB—central nervous system—epilepsy syndrome	3.62e-05	0.000429	CbGeAlD
Sunitinib—ABCG2—telencephalon—epilepsy syndrome	3.58e-05	0.000425	CbGeAlD
Sunitinib—PDGFRB—cerebellum—epilepsy syndrome	3.54e-05	0.00042	CbGeAlD
Sunitinib—KDR—brain—epilepsy syndrome	3.32e-05	0.000394	CbGeAlD
Sunitinib—MAP2K5—brain—epilepsy syndrome	3.32e-05	0.000394	CbGeAlD
Sunitinib—CSF1R—brain—epilepsy syndrome	3.24e-05	0.000384	CbGeAlD
Sunitinib—KCNH2—medulla oblongata—epilepsy syndrome	3.16e-05	0.000375	CbGeAlD
Sunitinib—ABCC4—head—epilepsy syndrome	3.16e-05	0.000375	CbGeAlD
Sunitinib—ABCC4—nervous system—epilepsy syndrome	2.99e-05	0.000355	CbGeAlD
Sunitinib—KIT—brain—epilepsy syndrome	2.94e-05	0.000349	CbGeAlD
Sunitinib—KCNH2—midbrain—epilepsy syndrome	2.89e-05	0.000343	CbGeAlD
Sunitinib—ABCC4—central nervous system—epilepsy syndrome	2.88e-05	0.000342	CbGeAlD
Sunitinib—PDGFRB—brain—epilepsy syndrome	2.87e-05	0.000341	CbGeAlD
Sunitinib—KCNH2—spinal cord—epilepsy syndrome	2.82e-05	0.000334	CbGeAlD
Sunitinib—ABCG2—medulla oblongata—epilepsy syndrome	2.81e-05	0.000334	CbGeAlD
Sunitinib—Dizziness—Diazepam—epilepsy syndrome	2.66e-05	0.000206	CcSEcCtD
Sunitinib—Infection—Valproic Acid—epilepsy syndrome	2.66e-05	0.000206	CcSEcCtD
Sunitinib—Leukopenia—Pregabalin—epilepsy syndrome	2.65e-05	0.000205	CcSEcCtD
Sunitinib—Rash—Fosphenytoin—epilepsy syndrome	2.64e-05	0.000205	CcSEcCtD
Sunitinib—Dermatitis—Fosphenytoin—epilepsy syndrome	2.64e-05	0.000204	CcSEcCtD
Sunitinib—Haemoglobin—Topiramate—epilepsy syndrome	2.64e-05	0.000204	CcSEcCtD
Sunitinib—Asthenia—Clonazepam—epilepsy syndrome	2.64e-05	0.000204	CcSEcCtD
Sunitinib—Back pain—Gabapentin—epilepsy syndrome	2.63e-05	0.000203	CcSEcCtD
Sunitinib—Headache—Fosphenytoin—epilepsy syndrome	2.63e-05	0.000203	CcSEcCtD
Sunitinib—Haemorrhage—Topiramate—epilepsy syndrome	2.63e-05	0.000203	CcSEcCtD
Sunitinib—Hepatitis—Topiramate—epilepsy syndrome	2.63e-05	0.000203	CcSEcCtD
Sunitinib—Nervous system disorder—Valproic Acid—epilepsy syndrome	2.62e-05	0.000203	CcSEcCtD
Sunitinib—Thrombocytopenia—Valproic Acid—epilepsy syndrome	2.62e-05	0.000203	CcSEcCtD
Sunitinib—Asthenia—Phenytoin—epilepsy syndrome	2.62e-05	0.000203	CcSEcCtD
Sunitinib—Nausea—Midazolam—epilepsy syndrome	2.61e-05	0.000202	CcSEcCtD
Sunitinib—Hypoaesthesia—Topiramate—epilepsy syndrome	2.61e-05	0.000202	CcSEcCtD
Sunitinib—Muscle spasms—Gabapentin—epilepsy syndrome	2.61e-05	0.000202	CcSEcCtD
Sunitinib—Diarrhoea—Zonisamide—epilepsy syndrome	2.61e-05	0.000202	CcSEcCtD
Sunitinib—Asthenia—Oxcarbazepine—epilepsy syndrome	2.6e-05	0.000202	CcSEcCtD
Sunitinib—Pruritus—Clonazepam—epilepsy syndrome	2.6e-05	0.000201	CcSEcCtD
Sunitinib—Vomiting—Vigabatrin—epilepsy syndrome	2.6e-05	0.000201	CcSEcCtD
Sunitinib—Skin disorder—Valproic Acid—epilepsy syndrome	2.6e-05	0.000201	CcSEcCtD
Sunitinib—Urinary tract disorder—Topiramate—epilepsy syndrome	2.59e-05	0.000201	CcSEcCtD
Sunitinib—Oedema peripheral—Topiramate—epilepsy syndrome	2.59e-05	0.0002	CcSEcCtD
Sunitinib—Cough—Pregabalin—epilepsy syndrome	2.59e-05	0.0002	CcSEcCtD
Sunitinib—Pruritus—Phenytoin—epilepsy syndrome	2.58e-05	0.0002	CcSEcCtD
Sunitinib—Connective tissue disorder—Topiramate—epilepsy syndrome	2.58e-05	0.0002	CcSEcCtD
Sunitinib—Nausea—Levetiracetam—epilepsy syndrome	2.58e-05	0.0002	CcSEcCtD
Sunitinib—Rash—Vigabatrin—epilepsy syndrome	2.58e-05	0.0002	CcSEcCtD
Sunitinib—Dizziness—Felbamate—epilepsy syndrome	2.58e-05	0.000199	CcSEcCtD
Sunitinib—Dermatitis—Vigabatrin—epilepsy syndrome	2.57e-05	0.000199	CcSEcCtD
Sunitinib—Urethral disorder—Topiramate—epilepsy syndrome	2.57e-05	0.000199	CcSEcCtD
Sunitinib—ABCG2—midbrain—epilepsy syndrome	2.57e-05	0.000305	CbGeAlD
Sunitinib—Pruritus—Oxcarbazepine—epilepsy syndrome	2.57e-05	0.000199	CcSEcCtD
Sunitinib—Convulsion—Pregabalin—epilepsy syndrome	2.57e-05	0.000199	CcSEcCtD
Sunitinib—Hypersensitivity—Carbamazepine—epilepsy syndrome	2.57e-05	0.000199	CcSEcCtD
Sunitinib—Headache—Vigabatrin—epilepsy syndrome	2.56e-05	0.000198	CcSEcCtD
Sunitinib—Hypertension—Pregabalin—epilepsy syndrome	2.56e-05	0.000198	CcSEcCtD
Sunitinib—Vomiting—Diazepam—epilepsy syndrome	2.56e-05	0.000198	CcSEcCtD
Sunitinib—Anorexia—Valproic Acid—epilepsy syndrome	2.55e-05	0.000197	CcSEcCtD
Sunitinib—Rash—Diazepam—epilepsy syndrome	2.54e-05	0.000196	CcSEcCtD
Sunitinib—Dermatitis—Diazepam—epilepsy syndrome	2.53e-05	0.000196	CcSEcCtD
Sunitinib—Myalgia—Pregabalin—epilepsy syndrome	2.52e-05	0.000195	CcSEcCtD
Sunitinib—Chest pain—Pregabalin—epilepsy syndrome	2.52e-05	0.000195	CcSEcCtD
Sunitinib—Arthralgia—Pregabalin—epilepsy syndrome	2.52e-05	0.000195	CcSEcCtD
Sunitinib—Dizziness—Zonisamide—epilepsy syndrome	2.52e-05	0.000195	CcSEcCtD
Sunitinib—Headache—Diazepam—epilepsy syndrome	2.52e-05	0.000195	CcSEcCtD
Sunitinib—Diarrhoea—Clonazepam—epilepsy syndrome	2.51e-05	0.000195	CcSEcCtD
Sunitinib—Anaemia—Gabapentin—epilepsy syndrome	2.51e-05	0.000194	CcSEcCtD
Sunitinib—ABCG2—spinal cord—epilepsy syndrome	2.51e-05	0.000297	CbGeAlD
Sunitinib—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	2.51e-05	0.000194	CcSEcCtD
Sunitinib—KCNH2—head—epilepsy syndrome	2.5e-05	0.000297	CbGeAlD
Sunitinib—Asthenia—Carbamazepine—epilepsy syndrome	2.5e-05	0.000193	CcSEcCtD
Sunitinib—Diarrhoea—Phenytoin—epilepsy syndrome	2.5e-05	0.000193	CcSEcCtD
Sunitinib—Nausea—Fosphenytoin—epilepsy syndrome	2.49e-05	0.000193	CcSEcCtD
Sunitinib—Diarrhoea—Oxcarbazepine—epilepsy syndrome	2.48e-05	0.000192	CcSEcCtD
Sunitinib—Erythema multiforme—Topiramate—epilepsy syndrome	2.48e-05	0.000192	CcSEcCtD
Sunitinib—Angioedema—Gabapentin—epilepsy syndrome	2.48e-05	0.000192	CcSEcCtD
Sunitinib—Hypersensitivity—Lamotrigine—epilepsy syndrome	2.48e-05	0.000192	CcSEcCtD
Sunitinib—Vomiting—Felbamate—epilepsy syndrome	2.48e-05	0.000192	CcSEcCtD
Sunitinib—Dry mouth—Pregabalin—epilepsy syndrome	2.47e-05	0.000191	CcSEcCtD
Sunitinib—Pruritus—Carbamazepine—epilepsy syndrome	2.46e-05	0.000191	CcSEcCtD
Sunitinib—Rash—Felbamate—epilepsy syndrome	2.46e-05	0.00019	CcSEcCtD
Sunitinib—Eye disorder—Topiramate—epilepsy syndrome	2.45e-05	0.00019	CcSEcCtD
Sunitinib—Dermatitis—Felbamate—epilepsy syndrome	2.45e-05	0.00019	CcSEcCtD
Sunitinib—Headache—Felbamate—epilepsy syndrome	2.44e-05	0.000189	CcSEcCtD
Sunitinib—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	2.44e-05	0.000189	CcSEcCtD
Sunitinib—Flushing—Topiramate—epilepsy syndrome	2.44e-05	0.000189	CcSEcCtD
Sunitinib—Cardiac disorder—Topiramate—epilepsy syndrome	2.44e-05	0.000189	CcSEcCtD
Sunitinib—Leukopenia—Gabapentin—epilepsy syndrome	2.43e-05	0.000188	CcSEcCtD
Sunitinib—Dizziness—Clonazepam—epilepsy syndrome	2.43e-05	0.000188	CcSEcCtD
Sunitinib—Nausea—Vigabatrin—epilepsy syndrome	2.43e-05	0.000188	CcSEcCtD
Sunitinib—Vomiting—Zonisamide—epilepsy syndrome	2.42e-05	0.000188	CcSEcCtD
Sunitinib—Insomnia—Valproic Acid—epilepsy syndrome	2.42e-05	0.000187	CcSEcCtD
Sunitinib—Oedema—Pregabalin—epilepsy syndrome	2.42e-05	0.000187	CcSEcCtD
Sunitinib—Asthenia—Lamotrigine—epilepsy syndrome	2.42e-05	0.000187	CcSEcCtD
Sunitinib—Dizziness—Phenytoin—epilepsy syndrome	2.41e-05	0.000187	CcSEcCtD
Sunitinib—Rash—Zonisamide—epilepsy syndrome	2.4e-05	0.000186	CcSEcCtD
Sunitinib—Infection—Pregabalin—epilepsy syndrome	2.4e-05	0.000186	CcSEcCtD
Sunitinib—Paraesthesia—Valproic Acid—epilepsy syndrome	2.4e-05	0.000186	CcSEcCtD
Sunitinib—Dermatitis—Zonisamide—epilepsy syndrome	2.4e-05	0.000186	CcSEcCtD
Sunitinib—Dizziness—Oxcarbazepine—epilepsy syndrome	2.4e-05	0.000186	CcSEcCtD
Sunitinib—Nausea—Diazepam—epilepsy syndrome	2.39e-05	0.000185	CcSEcCtD
Sunitinib—Headache—Zonisamide—epilepsy syndrome	2.39e-05	0.000185	CcSEcCtD
Sunitinib—Dyspnoea—Valproic Acid—epilepsy syndrome	2.39e-05	0.000185	CcSEcCtD
Sunitinib—Diarrhoea—Carbamazepine—epilepsy syndrome	2.38e-05	0.000185	CcSEcCtD
Sunitinib—Angiopathy—Topiramate—epilepsy syndrome	2.38e-05	0.000184	CcSEcCtD
Sunitinib—Pruritus—Lamotrigine—epilepsy syndrome	2.38e-05	0.000184	CcSEcCtD
Sunitinib—Shock—Pregabalin—epilepsy syndrome	2.38e-05	0.000184	CcSEcCtD
Sunitinib—KCNH2—nervous system—epilepsy syndrome	2.37e-05	0.000282	CbGeAlD
Sunitinib—Immune system disorder—Topiramate—epilepsy syndrome	2.37e-05	0.000184	CcSEcCtD
Sunitinib—Nervous system disorder—Pregabalin—epilepsy syndrome	2.37e-05	0.000184	CcSEcCtD
Sunitinib—Cough—Gabapentin—epilepsy syndrome	2.37e-05	0.000184	CcSEcCtD
Sunitinib—Thrombocytopenia—Pregabalin—epilepsy syndrome	2.37e-05	0.000183	CcSEcCtD
Sunitinib—Mediastinal disorder—Topiramate—epilepsy syndrome	2.37e-05	0.000183	CcSEcCtD
Sunitinib—Chills—Topiramate—epilepsy syndrome	2.36e-05	0.000182	CcSEcCtD
Sunitinib—Dyspepsia—Valproic Acid—epilepsy syndrome	2.36e-05	0.000182	CcSEcCtD
Sunitinib—Convulsion—Gabapentin—epilepsy syndrome	2.35e-05	0.000182	CcSEcCtD
Sunitinib—Skin disorder—Pregabalin—epilepsy syndrome	2.35e-05	0.000182	CcSEcCtD
Sunitinib—Hypertension—Gabapentin—epilepsy syndrome	2.35e-05	0.000182	CcSEcCtD
Sunitinib—Vomiting—Clonazepam—epilepsy syndrome	2.34e-05	0.000181	CcSEcCtD
Sunitinib—Decreased appetite—Valproic Acid—epilepsy syndrome	2.33e-05	0.00018	CcSEcCtD
Sunitinib—Alopecia—Topiramate—epilepsy syndrome	2.32e-05	0.00018	CcSEcCtD
Sunitinib—Vomiting—Phenytoin—epilepsy syndrome	2.32e-05	0.00018	CcSEcCtD
Sunitinib—Rash—Clonazepam—epilepsy syndrome	2.32e-05	0.000179	CcSEcCtD
Sunitinib—Dermatitis—Clonazepam—epilepsy syndrome	2.31e-05	0.000179	CcSEcCtD
Sunitinib—Arthralgia—Gabapentin—epilepsy syndrome	2.31e-05	0.000179	CcSEcCtD
Sunitinib—Chest pain—Gabapentin—epilepsy syndrome	2.31e-05	0.000179	CcSEcCtD
Sunitinib—Myalgia—Gabapentin—epilepsy syndrome	2.31e-05	0.000179	CcSEcCtD
Sunitinib—Nausea—Felbamate—epilepsy syndrome	2.31e-05	0.000179	CcSEcCtD
Sunitinib—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	2.31e-05	0.000179	CcSEcCtD
Sunitinib—Vomiting—Oxcarbazepine—epilepsy syndrome	2.31e-05	0.000179	CcSEcCtD
Sunitinib—Fatigue—Valproic Acid—epilepsy syndrome	2.31e-05	0.000179	CcSEcCtD
Sunitinib—Anorexia—Pregabalin—epilepsy syndrome	2.31e-05	0.000178	CcSEcCtD
Sunitinib—Dizziness—Carbamazepine—epilepsy syndrome	2.3e-05	0.000178	CcSEcCtD
Sunitinib—Diarrhoea—Lamotrigine—epilepsy syndrome	2.3e-05	0.000178	CcSEcCtD
Sunitinib—Headache—Clonazepam—epilepsy syndrome	2.3e-05	0.000178	CcSEcCtD
Sunitinib—Rash—Phenytoin—epilepsy syndrome	2.3e-05	0.000178	CcSEcCtD
Sunitinib—Mental disorder—Topiramate—epilepsy syndrome	2.3e-05	0.000178	CcSEcCtD
Sunitinib—Dermatitis—Phenytoin—epilepsy syndrome	2.3e-05	0.000178	CcSEcCtD
Sunitinib—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	2.3e-05	0.000178	CcSEcCtD
Sunitinib—Rash—Oxcarbazepine—epilepsy syndrome	2.29e-05	0.000177	CcSEcCtD
Sunitinib—Pain—Valproic Acid—epilepsy syndrome	2.29e-05	0.000177	CcSEcCtD
Sunitinib—Constipation—Valproic Acid—epilepsy syndrome	2.29e-05	0.000177	CcSEcCtD
Sunitinib—ABCC4—brain—epilepsy syndrome	2.29e-05	0.000271	CbGeAlD
Sunitinib—Dermatitis—Oxcarbazepine—epilepsy syndrome	2.29e-05	0.000177	CcSEcCtD
Sunitinib—Headache—Phenytoin—epilepsy syndrome	2.29e-05	0.000177	CcSEcCtD
Sunitinib—Malnutrition—Topiramate—epilepsy syndrome	2.29e-05	0.000177	CcSEcCtD
Sunitinib—Erythema—Topiramate—epilepsy syndrome	2.29e-05	0.000177	CcSEcCtD
Sunitinib—KCNH2—central nervous system—epilepsy syndrome	2.29e-05	0.000271	CbGeAlD
Sunitinib—Headache—Oxcarbazepine—epilepsy syndrome	2.27e-05	0.000176	CcSEcCtD
Sunitinib—Nausea—Zonisamide—epilepsy syndrome	2.26e-05	0.000175	CcSEcCtD
Sunitinib—Dry mouth—Gabapentin—epilepsy syndrome	2.26e-05	0.000175	CcSEcCtD
Sunitinib—Flatulence—Topiramate—epilepsy syndrome	2.25e-05	0.000174	CcSEcCtD
Sunitinib—Dysgeusia—Topiramate—epilepsy syndrome	2.24e-05	0.000173	CcSEcCtD
Sunitinib—KCNH2—cerebellum—epilepsy syndrome	2.23e-05	0.000265	CbGeAlD
Sunitinib—Dizziness—Lamotrigine—epilepsy syndrome	2.23e-05	0.000172	CcSEcCtD
Sunitinib—Oedema—Gabapentin—epilepsy syndrome	2.22e-05	0.000172	CcSEcCtD
Sunitinib—Vomiting—Carbamazepine—epilepsy syndrome	2.22e-05	0.000171	CcSEcCtD
Sunitinib—Back pain—Topiramate—epilepsy syndrome	2.21e-05	0.000171	CcSEcCtD
Sunitinib—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	2.2e-05	0.000171	CcSEcCtD
Sunitinib—Infection—Gabapentin—epilepsy syndrome	2.2e-05	0.000171	CcSEcCtD
Sunitinib—Muscle spasms—Topiramate—epilepsy syndrome	2.2e-05	0.00017	CcSEcCtD
Sunitinib—Rash—Carbamazepine—epilepsy syndrome	2.2e-05	0.00017	CcSEcCtD
Sunitinib—Dermatitis—Carbamazepine—epilepsy syndrome	2.19e-05	0.00017	CcSEcCtD
Sunitinib—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	2.19e-05	0.000169	CcSEcCtD
Sunitinib—Insomnia—Pregabalin—epilepsy syndrome	2.19e-05	0.000169	CcSEcCtD
Sunitinib—Nausea—Clonazepam—epilepsy syndrome	2.18e-05	0.000169	CcSEcCtD
Sunitinib—Headache—Carbamazepine—epilepsy syndrome	2.18e-05	0.000169	CcSEcCtD
Sunitinib—Shock—Gabapentin—epilepsy syndrome	2.18e-05	0.000169	CcSEcCtD
Sunitinib—Nervous system disorder—Gabapentin—epilepsy syndrome	2.18e-05	0.000168	CcSEcCtD
Sunitinib—Paraesthesia—Pregabalin—epilepsy syndrome	2.17e-05	0.000168	CcSEcCtD
Sunitinib—Thrombocytopenia—Gabapentin—epilepsy syndrome	2.17e-05	0.000168	CcSEcCtD
Sunitinib—Nausea—Phenytoin—epilepsy syndrome	2.17e-05	0.000168	CcSEcCtD
Sunitinib—Dyspnoea—Pregabalin—epilepsy syndrome	2.16e-05	0.000167	CcSEcCtD
Sunitinib—Nausea—Oxcarbazepine—epilepsy syndrome	2.16e-05	0.000167	CcSEcCtD
Sunitinib—Skin disorder—Gabapentin—epilepsy syndrome	2.15e-05	0.000167	CcSEcCtD
Sunitinib—Vomiting—Lamotrigine—epilepsy syndrome	2.14e-05	0.000166	CcSEcCtD
Sunitinib—Rash—Lamotrigine—epilepsy syndrome	2.12e-05	0.000164	CcSEcCtD
Sunitinib—Dermatitis—Lamotrigine—epilepsy syndrome	2.12e-05	0.000164	CcSEcCtD
Sunitinib—Body temperature increased—Valproic Acid—epilepsy syndrome	2.12e-05	0.000164	CcSEcCtD
Sunitinib—Abdominal pain—Valproic Acid—epilepsy syndrome	2.12e-05	0.000164	CcSEcCtD
Sunitinib—Anorexia—Gabapentin—epilepsy syndrome	2.11e-05	0.000164	CcSEcCtD
Sunitinib—Anaemia—Topiramate—epilepsy syndrome	2.11e-05	0.000164	CcSEcCtD
Sunitinib—Headache—Lamotrigine—epilepsy syndrome	2.11e-05	0.000163	CcSEcCtD
Sunitinib—Decreased appetite—Pregabalin—epilepsy syndrome	2.1e-05	0.000163	CcSEcCtD
Sunitinib—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	2.09e-05	0.000162	CcSEcCtD
Sunitinib—Fatigue—Pregabalin—epilepsy syndrome	2.09e-05	0.000161	CcSEcCtD
Sunitinib—Nausea—Carbamazepine—epilepsy syndrome	2.07e-05	0.00016	CcSEcCtD
Sunitinib—Pain—Pregabalin—epilepsy syndrome	2.07e-05	0.00016	CcSEcCtD
Sunitinib—Constipation—Pregabalin—epilepsy syndrome	2.07e-05	0.00016	CcSEcCtD
Sunitinib—Leukopenia—Topiramate—epilepsy syndrome	2.05e-05	0.000158	CcSEcCtD
Sunitinib—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	2.02e-05	0.000156	CcSEcCtD
Sunitinib—Insomnia—Gabapentin—epilepsy syndrome	2.01e-05	0.000155	CcSEcCtD
Sunitinib—Nausea—Lamotrigine—epilepsy syndrome	2e-05	0.000155	CcSEcCtD
Sunitinib—Cough—Topiramate—epilepsy syndrome	2e-05	0.000154	CcSEcCtD
Sunitinib—Paraesthesia—Gabapentin—epilepsy syndrome	1.99e-05	0.000154	CcSEcCtD
Sunitinib—ABCG2—cerebellum—epilepsy syndrome	1.99e-05	0.000236	CbGeAlD
Sunitinib—Convulsion—Topiramate—epilepsy syndrome	1.98e-05	0.000153	CcSEcCtD
Sunitinib—Gastrointestinal pain—Pregabalin—epilepsy syndrome	1.98e-05	0.000153	CcSEcCtD
Sunitinib—Dyspnoea—Gabapentin—epilepsy syndrome	1.98e-05	0.000153	CcSEcCtD
Sunitinib—Hypertension—Topiramate—epilepsy syndrome	1.97e-05	0.000153	CcSEcCtD
Sunitinib—Hypersensitivity—Valproic Acid—epilepsy syndrome	1.97e-05	0.000153	CcSEcCtD
Sunitinib—Dyspepsia—Gabapentin—epilepsy syndrome	1.95e-05	0.000151	CcSEcCtD
Sunitinib—Myalgia—Topiramate—epilepsy syndrome	1.95e-05	0.000151	CcSEcCtD
Sunitinib—Arthralgia—Topiramate—epilepsy syndrome	1.95e-05	0.000151	CcSEcCtD
Sunitinib—Chest pain—Topiramate—epilepsy syndrome	1.95e-05	0.000151	CcSEcCtD
Sunitinib—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	1.93e-05	0.00015	CcSEcCtD
Sunitinib—Decreased appetite—Gabapentin—epilepsy syndrome	1.93e-05	0.000149	CcSEcCtD
Sunitinib—Asthenia—Valproic Acid—epilepsy syndrome	1.92e-05	0.000149	CcSEcCtD
Sunitinib—ABCB1—forebrain—epilepsy syndrome	1.92e-05	0.000228	CbGeAlD
Sunitinib—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	1.91e-05	0.000148	CcSEcCtD
Sunitinib—Fatigue—Gabapentin—epilepsy syndrome	1.91e-05	0.000148	CcSEcCtD
Sunitinib—Body temperature increased—Pregabalin—epilepsy syndrome	1.91e-05	0.000148	CcSEcCtD
Sunitinib—Abdominal pain—Pregabalin—epilepsy syndrome	1.91e-05	0.000148	CcSEcCtD
Sunitinib—Dry mouth—Topiramate—epilepsy syndrome	1.9e-05	0.000147	CcSEcCtD
Sunitinib—Constipation—Gabapentin—epilepsy syndrome	1.9e-05	0.000147	CcSEcCtD
Sunitinib—Pain—Gabapentin—epilepsy syndrome	1.9e-05	0.000147	CcSEcCtD
Sunitinib—Pruritus—Valproic Acid—epilepsy syndrome	1.89e-05	0.000147	CcSEcCtD
Sunitinib—Oedema—Topiramate—epilepsy syndrome	1.87e-05	0.000144	CcSEcCtD
Sunitinib—Infection—Topiramate—epilepsy syndrome	1.85e-05	0.000144	CcSEcCtD
Sunitinib—Shock—Topiramate—epilepsy syndrome	1.84e-05	0.000142	CcSEcCtD
Sunitinib—Diarrhoea—Valproic Acid—epilepsy syndrome	1.83e-05	0.000142	CcSEcCtD
Sunitinib—Nervous system disorder—Topiramate—epilepsy syndrome	1.83e-05	0.000142	CcSEcCtD
Sunitinib—Thrombocytopenia—Topiramate—epilepsy syndrome	1.83e-05	0.000141	CcSEcCtD
Sunitinib—KCNH2—brain—epilepsy syndrome	1.81e-05	0.000215	CbGeAlD
Sunitinib—Gastrointestinal pain—Gabapentin—epilepsy syndrome	1.81e-05	0.00014	CcSEcCtD
Sunitinib—Skin disorder—Topiramate—epilepsy syndrome	1.81e-05	0.00014	CcSEcCtD
Sunitinib—Hypersensitivity—Pregabalin—epilepsy syndrome	1.78e-05	0.000138	CcSEcCtD
Sunitinib—Anorexia—Topiramate—epilepsy syndrome	1.78e-05	0.000138	CcSEcCtD
Sunitinib—Dizziness—Valproic Acid—epilepsy syndrome	1.77e-05	0.000137	CcSEcCtD
Sunitinib—ABCB1—telencephalon—epilepsy syndrome	1.76e-05	0.000209	CbGeAlD
Sunitinib—Abdominal pain—Gabapentin—epilepsy syndrome	1.75e-05	0.000136	CcSEcCtD
Sunitinib—Body temperature increased—Gabapentin—epilepsy syndrome	1.75e-05	0.000136	CcSEcCtD
Sunitinib—Asthenia—Pregabalin—epilepsy syndrome	1.74e-05	0.000134	CcSEcCtD
Sunitinib—Pruritus—Pregabalin—epilepsy syndrome	1.71e-05	0.000132	CcSEcCtD
Sunitinib—Vomiting—Valproic Acid—epilepsy syndrome	1.7e-05	0.000132	CcSEcCtD
Sunitinib—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	1.7e-05	0.000132	CcSEcCtD
Sunitinib—Insomnia—Topiramate—epilepsy syndrome	1.69e-05	0.000131	CcSEcCtD
Sunitinib—Rash—Valproic Acid—epilepsy syndrome	1.69e-05	0.000131	CcSEcCtD
Sunitinib—Dermatitis—Valproic Acid—epilepsy syndrome	1.69e-05	0.00013	CcSEcCtD
Sunitinib—Headache—Valproic Acid—epilepsy syndrome	1.68e-05	0.00013	CcSEcCtD
Sunitinib—Paraesthesia—Topiramate—epilepsy syndrome	1.68e-05	0.00013	CcSEcCtD
Sunitinib—Dyspnoea—Topiramate—epilepsy syndrome	1.66e-05	0.000129	CcSEcCtD
Sunitinib—Diarrhoea—Pregabalin—epilepsy syndrome	1.65e-05	0.000128	CcSEcCtD
Sunitinib—Dyspepsia—Topiramate—epilepsy syndrome	1.64e-05	0.000127	CcSEcCtD
Sunitinib—Hypersensitivity—Gabapentin—epilepsy syndrome	1.63e-05	0.000126	CcSEcCtD
Sunitinib—Decreased appetite—Topiramate—epilepsy syndrome	1.62e-05	0.000126	CcSEcCtD
Sunitinib—ABCG2—brain—epilepsy syndrome	1.61e-05	0.000192	CbGeAlD
Sunitinib—Gastrointestinal disorder—Topiramate—epilepsy syndrome	1.61e-05	0.000125	CcSEcCtD
Sunitinib—Fatigue—Topiramate—epilepsy syndrome	1.61e-05	0.000125	CcSEcCtD
Sunitinib—Dizziness—Pregabalin—epilepsy syndrome	1.6e-05	0.000124	CcSEcCtD
Sunitinib—Constipation—Topiramate—epilepsy syndrome	1.6e-05	0.000124	CcSEcCtD
Sunitinib—Pain—Topiramate—epilepsy syndrome	1.6e-05	0.000124	CcSEcCtD
Sunitinib—Asthenia—Gabapentin—epilepsy syndrome	1.59e-05	0.000123	CcSEcCtD
Sunitinib—Nausea—Valproic Acid—epilepsy syndrome	1.59e-05	0.000123	CcSEcCtD
Sunitinib—Pruritus—Gabapentin—epilepsy syndrome	1.57e-05	0.000121	CcSEcCtD
Sunitinib—Vomiting—Pregabalin—epilepsy syndrome	1.54e-05	0.000119	CcSEcCtD
Sunitinib—Gastrointestinal pain—Topiramate—epilepsy syndrome	1.53e-05	0.000118	CcSEcCtD
Sunitinib—Rash—Pregabalin—epilepsy syndrome	1.53e-05	0.000118	CcSEcCtD
Sunitinib—Dermatitis—Pregabalin—epilepsy syndrome	1.52e-05	0.000118	CcSEcCtD
Sunitinib—Diarrhoea—Gabapentin—epilepsy syndrome	1.52e-05	0.000117	CcSEcCtD
Sunitinib—Headache—Pregabalin—epilepsy syndrome	1.52e-05	0.000117	CcSEcCtD
Sunitinib—Body temperature increased—Topiramate—epilepsy syndrome	1.48e-05	0.000114	CcSEcCtD
Sunitinib—Abdominal pain—Topiramate—epilepsy syndrome	1.48e-05	0.000114	CcSEcCtD
Sunitinib—CYP3A4—nervous system—epilepsy syndrome	1.47e-05	0.000175	CbGeAlD
Sunitinib—Dizziness—Gabapentin—epilepsy syndrome	1.47e-05	0.000114	CcSEcCtD
Sunitinib—Nausea—Pregabalin—epilepsy syndrome	1.44e-05	0.000111	CcSEcCtD
Sunitinib—CYP3A4—central nervous system—epilepsy syndrome	1.42e-05	0.000168	CbGeAlD
Sunitinib—Vomiting—Gabapentin—epilepsy syndrome	1.41e-05	0.000109	CcSEcCtD
Sunitinib—Rash—Gabapentin—epilepsy syndrome	1.4e-05	0.000108	CcSEcCtD
Sunitinib—Dermatitis—Gabapentin—epilepsy syndrome	1.4e-05	0.000108	CcSEcCtD
Sunitinib—Headache—Gabapentin—epilepsy syndrome	1.39e-05	0.000108	CcSEcCtD
Sunitinib—ABCB1—medulla oblongata—epilepsy syndrome	1.39e-05	0.000165	CbGeAlD
Sunitinib—Hypersensitivity—Topiramate—epilepsy syndrome	1.37e-05	0.000106	CcSEcCtD
Sunitinib—Asthenia—Topiramate—epilepsy syndrome	1.34e-05	0.000104	CcSEcCtD
Sunitinib—Pruritus—Topiramate—epilepsy syndrome	1.32e-05	0.000102	CcSEcCtD
Sunitinib—Nausea—Gabapentin—epilepsy syndrome	1.32e-05	0.000102	CcSEcCtD
Sunitinib—Diarrhoea—Topiramate—epilepsy syndrome	1.28e-05	9.88e-05	CcSEcCtD
Sunitinib—ABCB1—midbrain—epilepsy syndrome	1.27e-05	0.00015	CbGeAlD
Sunitinib—ABCB1—spinal cord—epilepsy syndrome	1.24e-05	0.000147	CbGeAlD
Sunitinib—Dizziness—Topiramate—epilepsy syndrome	1.23e-05	9.55e-05	CcSEcCtD
Sunitinib—Vomiting—Topiramate—epilepsy syndrome	1.19e-05	9.18e-05	CcSEcCtD
Sunitinib—Rash—Topiramate—epilepsy syndrome	1.18e-05	9.11e-05	CcSEcCtD
Sunitinib—Dermatitis—Topiramate—epilepsy syndrome	1.18e-05	9.1e-05	CcSEcCtD
Sunitinib—Headache—Topiramate—epilepsy syndrome	1.17e-05	9.05e-05	CcSEcCtD
Sunitinib—Nausea—Topiramate—epilepsy syndrome	1.11e-05	8.58e-05	CcSEcCtD
Sunitinib—ABCB1—head—epilepsy syndrome	1.1e-05	0.00013	CbGeAlD
Sunitinib—ABCB1—nervous system—epilepsy syndrome	1.04e-05	0.000124	CbGeAlD
Sunitinib—ABCB1—central nervous system—epilepsy syndrome	1e-05	0.000119	CbGeAlD
Sunitinib—ABCB1—cerebellum—epilepsy syndrome	9.8e-06	0.000116	CbGeAlD
Sunitinib—ABCB1—brain—epilepsy syndrome	7.96e-06	9.45e-05	CbGeAlD
Sunitinib—PTK2B—Immune System—AKT1—epilepsy syndrome	2.75e-07	1.98e-06	CbGpPWpGaD
Sunitinib—RPS6KA5—Signaling Pathways—AKT1—epilepsy syndrome	2.74e-07	1.98e-06	CbGpPWpGaD
Sunitinib—NTRK1—Signaling Pathways—SRC—epilepsy syndrome	2.74e-07	1.97e-06	CbGpPWpGaD
Sunitinib—FYN—Innate Immune System—AKT1—epilepsy syndrome	2.72e-07	1.96e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—CYP2D6—epilepsy syndrome	2.72e-07	1.96e-06	CbGpPWpGaD
Sunitinib—FGFR1—Disease—SRC—epilepsy syndrome	2.72e-07	1.96e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—POMC—epilepsy syndrome	2.72e-07	1.96e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Disease—SRC—epilepsy syndrome	2.71e-07	1.96e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Immune System—SRC—epilepsy syndrome	2.71e-07	1.96e-06	CbGpPWpGaD
Sunitinib—RPS6KA2—Signaling Pathways—AKT1—epilepsy syndrome	2.71e-07	1.96e-06	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—RELA—epilepsy syndrome	2.71e-07	1.96e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Adaptive Immune System—AKT1—epilepsy syndrome	2.71e-07	1.96e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Innate Immune System—AKT1—epilepsy syndrome	2.7e-07	1.95e-06	CbGpPWpGaD
Sunitinib—JAK2—Immune System—JUN—epilepsy syndrome	2.7e-07	1.95e-06	CbGpPWpGaD
Sunitinib—BLK—Immune System—AKT1—epilepsy syndrome	2.68e-07	1.94e-06	CbGpPWpGaD
Sunitinib—ROCK1—Signaling Pathways—VEGFA—epilepsy syndrome	2.68e-07	1.94e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—HMOX1—epilepsy syndrome	2.68e-07	1.93e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	2.68e-07	1.93e-06	CbGpPWpGaD
Sunitinib—FGR—Immune System—AKT1—epilepsy syndrome	2.67e-07	1.93e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—PRKCB—epilepsy syndrome	2.67e-07	1.92e-06	CbGpPWpGaD
Sunitinib—NTRK1—Signaling Pathways—VEGFA—epilepsy syndrome	2.66e-07	1.92e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—CCL2—epilepsy syndrome	2.66e-07	1.92e-06	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—MTOR—epilepsy syndrome	2.66e-07	1.92e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—IL6ST—epilepsy syndrome	2.65e-07	1.92e-06	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—SRC—epilepsy syndrome	2.65e-07	1.91e-06	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—SRC—epilepsy syndrome	2.65e-07	1.91e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—POMC—epilepsy syndrome	2.65e-07	1.91e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—CAT—epilepsy syndrome	2.64e-07	1.91e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Immune System—SRC—epilepsy syndrome	2.64e-07	1.91e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—RELA—epilepsy syndrome	2.63e-07	1.9e-06	CbGpPWpGaD
Sunitinib—FYN—Adaptive Immune System—AKT1—epilepsy syndrome	2.61e-07	1.88e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—FGF2—epilepsy syndrome	2.61e-07	1.88e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—FGF2—epilepsy syndrome	2.6e-07	1.88e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—AQP1—epilepsy syndrome	2.6e-07	1.88e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—RELA—epilepsy syndrome	2.6e-07	1.87e-06	CbGpPWpGaD
Sunitinib—ABCB1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	2.59e-07	1.87e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—CCL2—epilepsy syndrome	2.59e-07	1.87e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—ADRA2A—epilepsy syndrome	2.59e-07	1.87e-06	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—SRC—epilepsy syndrome	2.59e-07	1.87e-06	CbGpPWpGaD
Sunitinib—JAK2—Innate Immune System—AKT1—epilepsy syndrome	2.58e-07	1.87e-06	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—VEGFA—epilepsy syndrome	2.58e-07	1.86e-06	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—VEGFA—epilepsy syndrome	2.58e-07	1.86e-06	CbGpPWpGaD
Sunitinib—CSNK1A1—Signaling Pathways—AKT1—epilepsy syndrome	2.58e-07	1.86e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—MTOR—epilepsy syndrome	2.58e-07	1.86e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—BCHE—epilepsy syndrome	2.58e-07	1.86e-06	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—CASP3—epilepsy syndrome	2.58e-07	1.86e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—ABCB1—epilepsy syndrome	2.57e-07	1.86e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—POMC—epilepsy syndrome	2.55e-07	1.84e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—RELA—epilepsy syndrome	2.55e-07	1.84e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—RELA—epilepsy syndrome	2.55e-07	1.84e-06	CbGpPWpGaD
Sunitinib—FYN—Immune System—SRC—epilepsy syndrome	2.55e-07	1.84e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—MTOR—epilepsy syndrome	2.55e-07	1.84e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—POMC—epilepsy syndrome	2.54e-07	1.83e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Immune System—SRC—epilepsy syndrome	2.53e-07	1.83e-06	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—VEGFA—epilepsy syndrome	2.52e-07	1.82e-06	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—JUN—epilepsy syndrome	2.5e-07	1.81e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Disease—SRC—epilepsy syndrome	2.5e-07	1.81e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—MTOR—epilepsy syndrome	2.5e-07	1.81e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—MTOR—epilepsy syndrome	2.5e-07	1.81e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—CCL2—epilepsy syndrome	2.5e-07	1.8e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—CCL2—epilepsy syndrome	2.49e-07	1.79e-06	CbGpPWpGaD
Sunitinib—ABCG2—Metabolism—POMC—epilepsy syndrome	2.46e-07	1.78e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—SLC2A1—epilepsy syndrome	2.46e-07	1.77e-06	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—CASP3—epilepsy syndrome	2.44e-07	1.76e-06	CbGpPWpGaD
Sunitinib—CYP3A7—Metabolism—POMC—epilepsy syndrome	2.44e-07	1.76e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Disease—SRC—epilepsy syndrome	2.44e-07	1.76e-06	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—MMP9—epilepsy syndrome	2.43e-07	1.76e-06	CbGpPWpGaD
Sunitinib—RPS6KA1—Signaling Pathways—AKT1—epilepsy syndrome	2.43e-07	1.76e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—PLCB1—epilepsy syndrome	2.43e-07	1.76e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—POMC—epilepsy syndrome	2.43e-07	1.75e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—TH—epilepsy syndrome	2.42e-07	1.75e-06	CbGpPWpGaD
Sunitinib—JAK2—Immune System—SRC—epilepsy syndrome	2.42e-07	1.75e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—RELA—epilepsy syndrome	2.42e-07	1.75e-06	CbGpPWpGaD
Sunitinib—FLT1—Signaling Pathways—AKT1—epilepsy syndrome	2.41e-07	1.74e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—RELA—epilepsy syndrome	2.41e-07	1.74e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—FGF2—epilepsy syndrome	2.4e-07	1.73e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—GPX1—epilepsy syndrome	2.39e-07	1.73e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—CCL2—epilepsy syndrome	2.38e-07	1.71e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—MTOR—epilepsy syndrome	2.37e-07	1.71e-06	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—JUN—epilepsy syndrome	2.37e-07	1.71e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—CASP3—epilepsy syndrome	2.37e-07	1.71e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—MTOR—epilepsy syndrome	2.37e-07	1.71e-06	CbGpPWpGaD
Sunitinib—FYN—Disease—SRC—epilepsy syndrome	2.35e-07	1.7e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	2.35e-07	1.7e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	2.35e-07	1.7e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—FGF2—epilepsy syndrome	2.34e-07	1.69e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—CASP3—epilepsy syndrome	2.34e-07	1.69e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Disease—SRC—epilepsy syndrome	2.34e-07	1.69e-06	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—MMP9—epilepsy syndrome	2.31e-07	1.67e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—JUN—epilepsy syndrome	2.3e-07	1.66e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—CASP3—epilepsy syndrome	2.3e-07	1.66e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—CASP3—epilepsy syndrome	2.3e-07	1.66e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—JUN—epilepsy syndrome	2.28e-07	1.64e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—FGF2—epilepsy syndrome	2.26e-07	1.63e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—FGF2—epilepsy syndrome	2.25e-07	1.62e-06	CbGpPWpGaD
Sunitinib—ABCG2—Metabolism—ALB—epilepsy syndrome	2.25e-07	1.62e-06	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—SRC—epilepsy syndrome	2.24e-07	1.62e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—MMP9—epilepsy syndrome	2.24e-07	1.62e-06	CbGpPWpGaD
Sunitinib—JAK2—Disease—SRC—epilepsy syndrome	2.24e-07	1.61e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—JUN—epilepsy syndrome	2.23e-07	1.61e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—JUN—epilepsy syndrome	2.23e-07	1.61e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—RELA—epilepsy syndrome	2.23e-07	1.61e-06	CbGpPWpGaD
Sunitinib—CYP3A7—Metabolism—ALB—epilepsy syndrome	2.23e-07	1.61e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—MMP9—epilepsy syndrome	2.21e-07	1.6e-06	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—VEGFA—epilepsy syndrome	2.19e-07	1.58e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—MTOR—epilepsy syndrome	2.19e-07	1.58e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—CASP3—epilepsy syndrome	2.18e-07	1.58e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—CASP3—epilepsy syndrome	2.18e-07	1.57e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—RELA—epilepsy syndrome	2.18e-07	1.57e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—MMP9—epilepsy syndrome	2.17e-07	1.57e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—MMP9—epilepsy syndrome	2.17e-07	1.57e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling by GPCR—AKT1—epilepsy syndrome	2.17e-07	1.57e-06	CbGpPWpGaD
Sunitinib—YES1—Immune System—AKT1—epilepsy syndrome	2.16e-07	1.56e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—FGF2—epilepsy syndrome	2.15e-07	1.55e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—MTOR—epilepsy syndrome	2.13e-07	1.54e-06	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—SRC—epilepsy syndrome	2.13e-07	1.54e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—JUN—epilepsy syndrome	2.12e-07	1.53e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—JUN—epilepsy syndrome	2.12e-07	1.53e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—AGT—epilepsy syndrome	2.1e-07	1.51e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—RELA—epilepsy syndrome	2.1e-07	1.51e-06	CbGpPWpGaD
Sunitinib—CSNK1E—Signaling Pathways—AKT1—epilepsy syndrome	2.09e-07	1.51e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—RELA—epilepsy syndrome	2.09e-07	1.51e-06	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—VEGFA—epilepsy syndrome	2.07e-07	1.5e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—SRC—epilepsy syndrome	2.07e-07	1.49e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—MMP9—epilepsy syndrome	2.06e-07	1.49e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—MMP9—epilepsy syndrome	2.06e-07	1.49e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—MTOR—epilepsy syndrome	2.06e-07	1.48e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—APOE—epilepsy syndrome	2.05e-07	1.48e-06	CbGpPWpGaD
Sunitinib—IRAK1—Immune System—AKT1—epilepsy syndrome	2.05e-07	1.48e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—MTOR—epilepsy syndrome	2.05e-07	1.48e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—SRC—epilepsy syndrome	2.04e-07	1.47e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—HMOX1—epilepsy syndrome	2.02e-07	1.46e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—VEGFA—epilepsy syndrome	2.01e-07	1.45e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—CASP3—epilepsy syndrome	2.01e-07	1.45e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—SRC—epilepsy syndrome	2e-07	1.45e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—SRC—epilepsy syndrome	2e-07	1.45e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—CAT—epilepsy syndrome	2e-07	1.44e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—RELA—epilepsy syndrome	1.99e-07	1.44e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—VEGFA—epilepsy syndrome	1.99e-07	1.43e-06	CbGpPWpGaD
Sunitinib—TYK2—Immune System—AKT1—epilepsy syndrome	1.99e-07	1.43e-06	CbGpPWpGaD
Sunitinib—ABCG2—Metabolism—PTGS2—epilepsy syndrome	1.97e-07	1.42e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—CASP3—epilepsy syndrome	1.96e-07	1.42e-06	CbGpPWpGaD
Sunitinib—FGFR2—Immune System—AKT1—epilepsy syndrome	1.96e-07	1.42e-06	CbGpPWpGaD
Sunitinib—PRKAA1—Signaling Pathways—AKT1—epilepsy syndrome	1.96e-07	1.41e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—MTOR—epilepsy syndrome	1.95e-07	1.41e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—JUN—epilepsy syndrome	1.95e-07	1.41e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—VEGFA—epilepsy syndrome	1.95e-07	1.41e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—VEGFA—epilepsy syndrome	1.95e-07	1.41e-06	CbGpPWpGaD
Sunitinib—CYP3A7—Metabolism—PTGS2—epilepsy syndrome	1.95e-07	1.41e-06	CbGpPWpGaD
Sunitinib—RPS6KA3—Signaling Pathways—AKT1—epilepsy syndrome	1.94e-07	1.4e-06	CbGpPWpGaD
Sunitinib—KIT—Immune System—AKT1—epilepsy syndrome	1.93e-07	1.39e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Immune System—AKT1—epilepsy syndrome	1.93e-07	1.39e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	1.92e-07	1.38e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—JUN—epilepsy syndrome	1.91e-07	1.38e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—SRC—epilepsy syndrome	1.9e-07	1.37e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—MMP9—epilepsy syndrome	1.9e-07	1.37e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—SRC—epilepsy syndrome	1.9e-07	1.37e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—CASP3—epilepsy syndrome	1.89e-07	1.36e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—CASP3—epilepsy syndrome	1.88e-07	1.36e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	1.87e-07	1.35e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	1.86e-07	1.34e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—MMP9—epilepsy syndrome	1.85e-07	1.34e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—VEGFA—epilepsy syndrome	1.85e-07	1.34e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—VEGFA—epilepsy syndrome	1.85e-07	1.33e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling by GPCR—AKT1—epilepsy syndrome	1.84e-07	1.33e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—JUN—epilepsy syndrome	1.84e-07	1.33e-06	CbGpPWpGaD
Sunitinib—TYK2—Disease—AKT1—epilepsy syndrome	1.83e-07	1.32e-06	CbGpPWpGaD
Sunitinib—FGFR1—Immune System—AKT1—epilepsy syndrome	1.83e-07	1.32e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—JUN—epilepsy syndrome	1.83e-07	1.32e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Immune System—AKT1—epilepsy syndrome	1.82e-07	1.32e-06	CbGpPWpGaD
Sunitinib—JAK2—GPCR downstream signaling—AKT1—epilepsy syndrome	1.81e-07	1.31e-06	CbGpPWpGaD
Sunitinib—FGFR2—Disease—AKT1—epilepsy syndrome	1.81e-07	1.31e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—GPX1—epilepsy syndrome	1.8e-07	1.3e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—CASP3—epilepsy syndrome	1.8e-07	1.3e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—MMP9—epilepsy syndrome	1.79e-07	1.29e-06	CbGpPWpGaD
Sunitinib—KIT—Disease—AKT1—epilepsy syndrome	1.78e-07	1.28e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—MMP9—epilepsy syndrome	1.78e-07	1.28e-06	CbGpPWpGaD
Sunitinib—PTK2B—Signaling Pathways—AKT1—epilepsy syndrome	1.78e-07	1.28e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—POMC—epilepsy syndrome	1.77e-07	1.27e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—SRC—epilepsy syndrome	1.75e-07	1.26e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—JUN—epilepsy syndrome	1.75e-07	1.26e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling by GPCR—AKT1—epilepsy syndrome	1.72e-07	1.24e-06	CbGpPWpGaD
Sunitinib—ROCK1—Signaling Pathways—AKT1—epilepsy syndrome	1.71e-07	1.23e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—SRC—epilepsy syndrome	1.71e-07	1.23e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—VEGFA—epilepsy syndrome	1.71e-07	1.23e-06	CbGpPWpGaD
Sunitinib—NTRK1—Signaling Pathways—AKT1—epilepsy syndrome	1.7e-07	1.23e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—MMP9—epilepsy syndrome	1.7e-07	1.23e-06	CbGpPWpGaD
Sunitinib—FGFR1—Disease—AKT1—epilepsy syndrome	1.69e-07	1.22e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Disease—AKT1—epilepsy syndrome	1.68e-07	1.22e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Immune System—AKT1—epilepsy syndrome	1.68e-07	1.22e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	1.68e-07	1.21e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—VEGFA—epilepsy syndrome	1.66e-07	1.2e-06	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—AKT1—epilepsy syndrome	1.65e-07	1.19e-06	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—AKT1—epilepsy syndrome	1.65e-07	1.19e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—SRC—epilepsy syndrome	1.65e-07	1.19e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling by GPCR—AKT1—epilepsy syndrome	1.65e-07	1.19e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Immune System—AKT1—epilepsy syndrome	1.64e-07	1.19e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—SRC—epilepsy syndrome	1.64e-07	1.18e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—ALB—epilepsy syndrome	1.61e-07	1.16e-06	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—AKT1—epilepsy syndrome	1.61e-07	1.16e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—VEGFA—epilepsy syndrome	1.6e-07	1.16e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—VEGFA—epilepsy syndrome	1.6e-07	1.15e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	1.59e-07	1.15e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—BCHE—epilepsy syndrome	1.59e-07	1.15e-06	CbGpPWpGaD
Sunitinib—FYN—Immune System—AKT1—epilepsy syndrome	1.58e-07	1.14e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—AGT—epilepsy syndrome	1.58e-07	1.14e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Immune System—AKT1—epilepsy syndrome	1.58e-07	1.14e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—SRC—epilepsy syndrome	1.57e-07	1.13e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Disease—AKT1—epilepsy syndrome	1.55e-07	1.12e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—APOE—epilepsy syndrome	1.55e-07	1.12e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—VEGFA—epilepsy syndrome	1.53e-07	1.1e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Disease—AKT1—epilepsy syndrome	1.52e-07	1.09e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	1.51e-07	1.09e-06	CbGpPWpGaD
Sunitinib—JAK2—Immune System—AKT1—epilepsy syndrome	1.51e-07	1.09e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	1.5e-07	1.08e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—TH—epilepsy syndrome	1.49e-07	1.08e-06	CbGpPWpGaD
Sunitinib—FYN—Disease—AKT1—epilepsy syndrome	1.46e-07	1.06e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Disease—AKT1—epilepsy syndrome	1.45e-07	1.05e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—PTGS2—epilepsy syndrome	1.41e-07	1.02e-06	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—AKT1—epilepsy syndrome	1.39e-07	1.01e-06	CbGpPWpGaD
Sunitinib—JAK2—Disease—AKT1—epilepsy syndrome	1.39e-07	1e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—POMC—epilepsy syndrome	1.33e-07	9.61e-07	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—AKT1—epilepsy syndrome	1.32e-07	9.55e-07	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—AKT1—epilepsy syndrome	1.28e-07	9.27e-07	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—AKT1—epilepsy syndrome	1.27e-07	9.15e-07	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	1.25e-07	8.99e-07	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—AKT1—epilepsy syndrome	1.25e-07	8.99e-07	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—AKT1—epilepsy syndrome	1.25e-07	8.99e-07	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—CAT—epilepsy syndrome	1.23e-07	8.87e-07	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—ALB—epilepsy syndrome	1.21e-07	8.77e-07	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	1.2e-07	8.63e-07	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—AKT1—epilepsy syndrome	1.18e-07	8.53e-07	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—AKT1—epilepsy syndrome	1.18e-07	8.51e-07	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—GPX1—epilepsy syndrome	1.11e-07	8.03e-07	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—AKT1—epilepsy syndrome	1.09e-07	7.86e-07	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—PTGS2—epilepsy syndrome	1.06e-07	7.67e-07	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—AKT1—epilepsy syndrome	1.06e-07	7.67e-07	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—AKT1—epilepsy syndrome	1.02e-07	7.39e-07	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—AKT1—epilepsy syndrome	1.02e-07	7.35e-07	CbGpPWpGaD
Sunitinib—ABCG2—Metabolism—AKT1—epilepsy syndrome	9.88e-08	7.13e-07	CbGpPWpGaD
Sunitinib—CYP3A7—Metabolism—AKT1—epilepsy syndrome	9.79e-08	7.07e-07	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—AGT—epilepsy syndrome	9.75e-08	7.04e-07	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—AKT1—epilepsy syndrome	9.73e-08	7.03e-07	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—APOE—epilepsy syndrome	9.55e-08	6.9e-07	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—POMC—epilepsy syndrome	8.21e-08	5.92e-07	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—ALB—epilepsy syndrome	7.48e-08	5.4e-07	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—AKT1—epilepsy syndrome	7.08e-08	5.11e-07	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	6.55e-08	4.72e-07	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—AKT1—epilepsy syndrome	5.34e-08	3.85e-07	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—AKT1—epilepsy syndrome	3.29e-08	2.37e-07	CbGpPWpGaD
